Answers are grounded in this paper and cite their sources.
Key massageTarget trial emulation of 3,541 intensive care unit patients shows no mortality benefit from personalizing glucose targets using admission HbA1c.Individualized, NICE-SUGAR and usual-care strategies, all produced nearly identical 30-day intensive care unit mortality.
No takes yet. Share an insight, caveat, or question.
Furler et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: